Back to JHPCYView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery
View Full LandscapeDrug Information
Target Indication
Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery
Clinical Trial
NCT06507436Last updated: 10/16/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
JSKN003Phase 3
Advanced Solid Tumor
Irinotecan liposome、5-Fluorouracil、LeucovorinPhase 3
Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy
X0002 SprayPhase 3
KNEE OSTEOARTHRITIS
RocuroniumPhase 3
Neuromuscular Blockade
HRS-9190Phase 3
Neuromuscular Blockade
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts